Related Experiment Videos

[Management of cardiovascular risk factors in type 2 diabetes mellitus]

M Brändle1, G A Spinas

  • 1Abteilung für Endokrinologie/Diabetologie, Departement für Innere Medizin, Universitätsspital Zürich. mbrandle@umich.edu

Therapeutische Umschau. Revue Therapeutique
|September 19, 2002
PubMed

Insights

Managing cardiovascular disease risk factors is crucial for individuals with type 2 diabetes. Aggressive control of hyperglycemia, hypertension, dyslipidemia, and smoking significantly reduces morbidity and mortality.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is the leading cause of death in type 2 diabetes mellitus (T2DM).
  • Individuals with T2DM face a higher CVD risk compared to those without diabetes, even with identical risk factors.
  • Key independent risk factors for CVD in T2DM include hyperglycemia, hypertension, dyslipidemia, and smoking.

Purpose of the Study:

  • To emphasize the critical importance of cardiovascular risk factor modification in patients with T2DM.
  • To highlight the benefits of interventions for primary and secondary prevention of CVD in this population.
  • To outline specific therapeutic targets for risk factor management.

Main Methods:

  • Review of existing literature and clinical guidelines on CVD risk management in T2DM.
  • Analysis of the impact of various risk factors on cardiovascular outcomes.
  • Evaluation of the efficacy of lifestyle modifications and pharmacological interventions.

Main Results:

  • Risk factor modification yields significant benefits for T2DM patients, comparable to or exceeding benefits in non-diabetic individuals.
  • Lifestyle changes including physical activity, healthy diet, weight loss, and smoking cessation are essential.
  • Optimal glycemic control (HbA1c < 7%), aggressive hypertension management (< 130/80 mmHg), and dyslipidemia control are crucial.
  • Aspirin (100 mg/d) is recommended for secondary prevention and considered for primary prevention in high-risk T2DM patients.

Conclusions:

  • Proactive and aggressive management of cardiovascular risk factors is paramount for improving outcomes in type 2 diabetes.
  • A multi-faceted approach combining lifestyle changes, glycemic control, blood pressure management, lipid-lowering therapies, and potentially aspirin is necessary.
  • Early and consistent intervention can substantially reduce the burden of cardiovascular morbidity and mortality in T2DM.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...